AMED Forecast and Technical Stock Analysis
Hold candidate since 2020-01-24 PDF
Amedisys Inc fell by -0.75% in the last day ( Friday, 24th Jan 2020 ) from $180.34 to $178.98 and has now fallen 3 days in a row. During the day the stock fluctuated 2.49% from a day low at $176.12 to a day high of $180.51. The price has risen in 6 of the last 10 days and is up by 3.66% over the past 2 weeks. Volume has increased in the last day by 61 392 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 190 132 shares bought and sold for approximately $34.03 million.
- 30 day high of the AMED stock price was $184.78 and low was $162.70.
- 90 day high was $184.78 and low was $127.12.
- 52 week high for Amedisys Inc - $184.78 and low - $106.65.
Amedisys Inc lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 26.02% during the next 3 months and, with 90% probability hold a price between $208.00 and $238.65 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Thursday January 16, 2020, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Amedisys Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $179.92. On a fall, the stock will find some support from the long-term average at approximately $169.09. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
The stock holds a RSI14 at 76 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $166.92 and $147.43.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Amedisys Inc finds support just below today's level at $166.92. If this is broken, then the next support from accumulated volume will be at $147.43 and $146.50.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $4.39 (2.49%) between high and low. For the last week, the stock has had daily average volatility of 2.09%.
Our recommended stop-loss: $173.07 (-3.30%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 76 and this increases the risk substantially. There is a sell signal from pivot top found 5 day(s) ago.)
2.09 %Average volatility
Very Low Low Medium High Very High
Amedisys Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate candidate.
|AMED $178.98 ($-1.36 -0.75%)|
AMED is down $1.36 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for AMED based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AMED analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.